EDGAR Verified
Primary Source · SEC.gov

SEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP

CIK 0001998268Fund Vehicle2023 vintage506(b), 3(c)(1)

Raised

$1M

Investors

2

Min Invest

$112,730

AltStreet Analysis

·

Generated from EDGAR primary sources

Seroba Life Sciences Fund IV Limited Partnership is an Ireland-domiciled pooled investment fund that filed under Rule 506(b) and Section 3(c)(1) on 2023-10-26. The fund reported $1.0M raised from 2 investors with a minimum investment of $113K. This is a standalone filing with no matched parent platform in the AltStreet database.

This fund follows the typical exemption pattern for private investment vehicles—506(b) for capital formation and 3(c)(1) for Investment Company Act exclusion. The $113K minimum investment is accessible relative to many institutional alternative funds, though the offshore Ireland domicile suggests a cross-border structure common in life sciences venture investing.

Data Flags

generalIreland incorporation filing Form D indicates cross-border fund structure
total_investorsOnly 2 investors for $1.0M raised suggests initial close or anchor commitments ($500K average check per investor)

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001998268
Entity NameSEROBA LIFE SCIENCES FUND IV LIMITED PARTNERSHIP
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateOctober 26, 2023
Accession Number0001998268-23-000001
Total Amount Sold$1M
Total Investors2
Minimum Investment$112,730
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

N/A SEROBA LIFE SCIENCES (GP IV) LIMITED

Executive Officer, Director · DUBLIN 2, L2

N/A SEROBA LIFE SCIENCES MANAGEMENT LIMITED

Executive Officer · DUBLIN 2, L2

PETER SANDYS

Director · DUBLIN 2, L2

ALAN O'CONNELL

Director · DUBLIN 2, L2

DANIEL O'MAHONY

Director · DUBLIN 2, L2

BRUNO MONTANARI

Director · DUBLIN 2, L2

ANDREW DUIGNAN

Executive Officer, Director · DUBLIN 2, L2

JENNIFER MCMAHON

Director · DUBLIN 2, L2

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.